REPL - Replimune Group GAAP EPS of -$0.79 misses by $0.01
- Replimune Group press release ( NASDAQ: REPL ): Q2 GAAP EPS of -$0.79 misses by $0.01 .
- As of September 30, 2022, cash, cash equivalents and short-term investments were $371.8 million, as compared to $395.7 million as of fiscal year end March 31, 2022.
For further details see:
Replimune Group GAAP EPS of -$0.79 misses by $0.01